Exploring the contribution of COVID-19 prevention network to SARS-CoV-2 vaccine efficacy clinical trials

By | January 25, 2023
Researchers described the coronavirus disease 2019 (COVID-19) prevention network (CoVPN) and its contribution to clinical efficacy evaluations of COVID-19 vaccines in phase 3 trials.